Amedisys, Inc. (AMED) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate Amedisys, Inc.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
68.78
Weak
WeakModerateStrong
P/B Ratio
2.62
Strong
WeakModerateStrong
Earnings Yield
1.46%
Yield Trap
WeakModerateStrong
Profitability Health
2024Return on Equity
3.81%
Weak
WeakModerateStrong
Operating Margin
4.03%
Weak
WeakModerateStrong
Net Profit Margin
1.84%
Weak
WeakModerateStrong
Growth Indicators
2024Revenue Growth
5.01%
Moderate
WeakModerateStrong
Net Income Growth
543.53%
Strong
WeakModerateStrong
EPS Growth
540.00%
Strong
WeakModerateStrong
Efficiency & Liquidity
2024Current Ratio
1.23
Moderate
WeakModerateStrong
Quick Ratio
1.23
Moderate
WeakModerateStrong
Asset Turnover
1.10x
Strong
WeakModerateStrong
Inventory Turnover
-
No data
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
7.21%
Strong
WeakModerateStrong
EV / Free Cash Flow
14.59x
Strong
WeakModerateStrong
Net Debt / EBITDA
2.14x
Weak
WeakModerateStrong
Interest Burden (EBT / EBIT)
0.912
Moderate
WeakModerateStrong
Return on Invested Capital
2.44%
Weak
WeakModerateStrong
Cash Conversion Cycle
36.92 days
Weak
WeakModerateStrong
Fortress screener guardrails
1/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for AMED.
View Financial Statements